- Statutory Instrument 2004 No. 1480
The Medicines (Advertising) Amendment Regulations 2004
© Crown Copyright 2004
Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.
The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.
It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.
The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Medicines (Advertising) Amendment Regulations 2004, ISBN 0110493664. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail: customer.services@tso.co.uk.
Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions.
To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
| Made | 4th June 2004 | ||
| Laid before Parliament | 9th June 2004 | ||
| Coming into force | 30th June 2004 |
The Secretary of State, in exercise of the powers conferred on him by section 2(2) of the European Communities Act 1972[1], being designated for the purposes of section 2(2) of the Act in relation to medicinal products[2] and, as respects England, Scotland and Wales, the Secretary of State concerned with health in England, and, as respects Northern Ireland, the Department of Health, Social Services and Public Safety, acting jointly, in exercise of the powers conferred on them by sections 95(1)(b) and (c) and 129(5) of the Medicines Act 1968[3] or, as the case may be, the powers conferred by those provisions and now vested in them[4], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations pursuant to section 129(6) of that Act, and after taking into account the advice of the Medicines Commission pursuant to section 129(7) of that Act, hereby make the following Regulations: -
Citation and commencement
1. These Regulations may be cited as the Medicines (Advertising) Amendment Regulations 2004 and shall come into force on the 30th June 2004.
Amendment of the Medicines (Advertising) Regulations 1994
2. The Medicines (Advertising) Regulations 1994[5] shall be amended as follows -
-
(a) in regulation 6 (prohibition of advertisements referring to specified diseases) -
-
(i) in paragraph (1), omit "paragraph (2) and to", and
(ii) omit paragraph (2); and
(b) for Schedule 1 substitute -
Chronic insomnia
Diabetes and other metabolic diseases
Malignant diseases
Serious infectious diseases including HIV-related diseases and tuberculosis
Sexually transmitted diseases.".
Signed by authority of the Secretary of State for Health
Warner
Parliamentary Under Secretary of State, Department of Health
27th May 2004
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
D. C. Gowdy
Permanent Secretary, Department of Health, Social Services and Public Safety
4th June 2004
(This note is not part of the Regulations)
These Regulations further amend the Medicines (Advertising) Regulations 1994 which implemented parts of Council Directive 92/28/EEC (OJ No. L113, 30.4.92, p.13) concerning the advertising of medicinal products for human use and parts of Council Directive 92/73/EEC (OJ No. L297, 13.10.1992, p.8) concerning homeopathic medicinal products for human use; both of which are now repealed and re-enacted by Directive 2001/83/EC (OJ No. L311, 28.11.2001, p.67) (see Title VIII in relation to advertising).
The Regulations amend regulation 6 and Schedule 1, which implemented article 3(2) of Council Directive 92/28/EEC (see now Article 88(2) of Directive 2001/83/EC). They remove the prohibition on advertising to the public medicinal products for the treatment, prevention or diagnosis of bone, cardiovascular, endocrine, psychiatric and joint, rheumatic and collagen diseases, genetic disorders, diseases of the liver, biliary system and pancreas, serious disorders of the eye and ear, serious gastrointestinal, neurological and muscular, renal and respiratory diseases, and serious skin disorders.
The prohibition on advertising medicinal products for chronic insomnia, diabetes and other metabolic diseases, malignant diseases, serious infectious diseases and sexually transmitted diseases remains.
A Regulatory Impact Assessment in relation to these Regulations has been placed in the libraries of both Houses of Parliament and copies may be obtained from the Medicines and Healthcare products Regulatory Agency, Information Centre, Room 10-202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.
Notes:
[1] 1972 c. 68.back
[3] 1968 c. 67; the expression "the appropriate Ministers" and the expression the "Health Ministers", which are relevant to the powers being exercised in the making of these regulations, are defined in section 1 of that Act as amended by article 2(2) of, and Schedule 1 to, S.I. 1969/388, and by articles 2(1) and 5 of, and the Schedule to, S.I. 1999/3142.back
[4] In the case of the Secretary of State concerned with health in England, by virtue of article 2(2) of, and Schedule 1 to, S.I. 1969/388, and articles 2(1) and 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; and in the case of the Department for Health, Social Services and Public Safety, by virtue of the powers vested in the Minister in charge of that Department by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47) which may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c. 1); the Department was renamed by virtue of Article 3(6) of S.I. 1999/283 (N.I.1).back
[5] S.I. 1994/1932; the relevant amending instrument is S.I. 1996/1552.back
ISBN 0 11 049366 4